title: Neratinib in ERBB2-Positive Brain Metastases.
authors.affiliation: Stanford School of Medicine, Stanford Womens Cancer Center, Stanford, California.
authors.forename: Mark D
authors.initials: MD
authors.lastname: Pegram
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology / Q000556:secondary; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D005260:Female; D006801:Humans; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics
chemical_list: D018719:Erb-b2 Receptor Tyrosine Kinases